Mirena 52 MG systems
Ended Awarded Last action
- Contract number
- SPE2DR26FCFR3
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,950
Award facts
- Contract value 100% obligated
- $10,949.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $10,949.60 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Mirena 52 mg contraceptive systems. The award, issued on January 29, 2026, with an ultimate completion date of February 20, 2026, utilizes firm fixed-price pricing with no set-aside designation, indicating the vendor competed in unrestricted federal procurement. This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to establish multiple regional prime vendor contractors supplying pharmaceutical products to Department of Defense military healthcare facilities worldwide.
DMS Pharmaceutical Group's IDC, designated contract SPE2DR and awarded on November 13, 2025, carries a $499.999 billion ceiling value through December 31, 2036, with a 30-month base period followed by three 30-month option periods. As a critical pharmaceutical supplier within the federal military medical supply chain, the company maintains an extensive portfolio encompassing branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables. The company's demonstrated performance across numerous delivery orders issued by the Defense Logistics Agency's Medical Supply Chain division establishes its capability to fulfill the diverse pharmaceutical requirements supporting DoD healthcare operations globally.
Quick answers
Who was awarded contract SPE2DR26FCFR3?
SPE2DR26FCFR3 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26FCFR3 worth?
The government has obligated $10,950 on SPE2DR26FCFR3.
Is contract SPE2DR26FCFR3 an order under another contract?
Yes. SPE2DR26FCFR3 is a delivery order under SPE2DR25D9133, an indefinite delivery contract.
Was contract SPE2DR26FCFR3 competed?
The extent of competition for SPE2DR26FCFR3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award